Showing 13–24 of 65 results

Show sidebar

IBRUTIX 140 MG

Product Description: Ibrutix (Ibrutinib) is a kinase inhibitor indicated for the treatment of patients with: Mantle Cell Lymphoma (MCL) who

IBRUXEN 140 MG

 Ibruxen Capsule Ibrutinib 140 mg Everest Pharmaceuticals Ltd. Indications Mantle Cell Lymphoma: Ibrutinib is indicated for the treatment of patients with

JUPARIB 150 MG

 Juparib Tablet Olaparib 150 mg Julphar Bangladesh Ltd.  Also available as: 100 mg Indications Breast Cancer: Olaparib is indicated as monotherapy

LAPANIX 250 MG

LAPANIX 250 MG Lapatinib Beacon Pharmaceuticals Ltd. Product Description: Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase

LARONIB 100 MG

DESCRIPTION Laronib Larotrectinib 25 mg & 100 mg COMPOSITION LARONIB 25 capsules: Each capsule contains Larotrectinib Sulfate INN equivalent to

LARONIB 25 MG

DESCRIPTION Laronib Larotrectinib 25 mg & 100 mg COMPOSITION LARONIB 25 capsules: Each capsule contains Larotrectinib Sulfate INN equivalent to

LENVAXEN 10 MG

DESCRIPTION Lenvaxen Lenvatinib 4 mg & 10 mg COMPOSITION LENVAXEN 4 capsules: Each capsule contains Lenvatinib Mesylate INN equivalent to

LENVAXEN 4 MG

DESCRIPTION Lenvaxen Lenvatinib 4 mg & 10 mg COMPOSITION LENVAXEN 4 capsules: Each capsule contains Lenvatinib Mesylate INN equivalent to

LEVAT 10 MG

 Levat Capsule Lenvatinib Mesylate 10 mg Julphar Bangladesh Ltd. Indications Lenvatinib is a kinase inhibitor that is indicated:  For the treatment